flecainide has been researched along with lidocaine in 134 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 41 (30.60) | 18.7374 |
1990's | 45 (33.58) | 18.2507 |
2000's | 30 (22.39) | 29.6817 |
2010's | 17 (12.69) | 24.3611 |
2020's | 1 (0.75) | 2.80 |
Authors | Studies |
---|---|
Argentieri, TM; Gomez, RP; Lind, JM; Morgan, TK; Nickisch, K; Phillips, GB; Sullivan, ME; Wohl, RA | 1 |
Barcelon-Yang, C; Black, LA; Brown, BS; Matier, WL; Quon, CY; Stampfli, HF; Stout, DM | 1 |
Baizman, ER; Becker, C; Bell, RH; Birsner, NC; Bohnet, EA; Busacca, CA; Carabateas, PM; Chadwick, CC; Gruett, MD; Johnson, RE | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Abraham, S; Barrett, TD; Beatch, GN; Clohs, L; Dong, Y; Fedida, D; Jung, GL; Liu, Y; Lynn, L; Plouvier, B; Sheng, T; Walker, MJ; Wall, RA; Wang, WQ; Zhu, JJ; Zolotoy, A | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Glen, RC; Lowe, R; Mitchell, JB | 1 |
Sen, S; Sinha, N | 1 |
Bellman, K; Knegtel, RM; Settimo, L | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Arita, M; Kiyosue, T; Sato, T; Wu, B | 1 |
Kato, R; Koide, M; Miyahara, T; Sotobata, I; Toyama, J; Ukai, M; Yasui, S; Yokota, M | 1 |
Hsieh, MZ; Penz, W; Pugsley, M; Walker, MJ | 1 |
Ikeda, N; Kamiya, K | 1 |
Rabkin, SW | 1 |
Hashimoto, H; Katoh, H; Nakashima, M | 1 |
Campbell, TJ; Pallandi, R; Wyse, KR | 1 |
Asayama, J; Inoue, D; Inoue, M; Katsume, H; Nakagawa, M; Shirayama, T; Tatsumi, T; Yamahara, Y | 1 |
Fukami, M; Hashimoto, T; Itoh, Y; Koike, H; Kumakura, S; Miyake, S; Mizuno, H; Shiga, H; Shimoji, Y; Yorikane, R | 1 |
Akaike, N; Inomata, N; Ishihara, T | 1 |
Duker, BG | 1 |
Cheymol, G; Chézalviel, F; Davy, JM; Engel, F; Ertzbischoff, O; Lainée, P; Motté, G; Penin, E; Poirier, JM; Weissenburger, J | 1 |
Camm, AJ; Garratt, CJ; Griffith, MJ; Linker, NJ; Ward, DE | 1 |
Desai, DM; Gal, J; Meyer-Lehnert, S | 1 |
Keefe, DL; Miura, D; Somberg, JC | 1 |
Grauer, K; Gums, J; Skluth, H | 1 |
Hoffman, BF; Spinelli, W | 1 |
Bleske, BE; Chow, MS; Fisher, J; Kluger, J | 1 |
Somberg, J | 1 |
Roden, DM; Siddoway, LA; Woosley, RL | 1 |
Roy, D | 1 |
Engel, T; Kelliher, GJ; Kowey, P; Wetstein, L | 1 |
Echt, DS; Roden, DM; Woosley, RL | 1 |
Morganroth, J; Nestico, PF | 2 |
Huang, SK; Marcus, FI | 1 |
Light, RT; Onrot, J; Robertson, D; Robertson, RM; Tantengco, MV | 1 |
Kates, RE | 1 |
Horowitz, LN; Morganroth, J | 1 |
Frais, MA; Hafizullah, M; Jackson, NC; Kalra, PA; Reynolds, GW; Silke, B; Taylor, SH; Verma, SP | 1 |
Bauman, JL; Gallastegui, J; Hariman, RJ; Tanenbaum, SR | 1 |
Hammill, SC; Kreeger, RW | 1 |
Baedeker, W; Barthel, P; Blömer, H; Goedel-Meinen, L; Hofmann, M; Schmidt, G | 1 |
Fingerhood, M; Keefe, D; Maza, S; Miura, D; Somberg, JC; Wynn, J | 1 |
Collignon, P; Legrand, V | 1 |
Podrid, PJ | 1 |
Sanna, GP | 1 |
Hillis, WS; Whiting, B | 1 |
Somberg, JC | 1 |
Duff, HJ; Oates, JA; Roden, DM; Woosley, RL | 1 |
Block, PJ; Winkle, RA | 1 |
Pottage, A | 1 |
Harrison, DC; Mead, RH | 1 |
McDevitt, DG | 1 |
Hugenholtz, PG; Serruys, PW; Vanhaleweyk, G | 1 |
Camm, AJ | 1 |
Orning, OM | 1 |
Hellestrand, KJ | 1 |
Luck, JC; Mann, DE; Pratt, CM; Wyndham, CR | 1 |
Banitt, EH; Kvam, DC; Schmid, JR | 1 |
Bexton, RS; Burnett, PJ; Camm, AJ; Debbas, NM; Hellestrand, KJ; Milne, JR | 1 |
Atallah, G; Kirkorian, G; Moleur, P; Touboul, P | 1 |
Bender, F; Gülker, H; Heuer, H; Hübner, G; Kristek, J; Schindelhauer, F; Thale, J | 1 |
Haruno, A; Hashimoto, K | 1 |
Asayama, J; Inoue, D; Inoue, M; Ishibashi, K; Nakagawa, M; Sakai, R; Shirayama, T | 1 |
Chi, L; Fagbemi, SO; Lucchesi, BR | 1 |
Lee, JK; Nonokawa, M; Sugiyama, T; Takanaka, C; Yame, S | 1 |
Gutiérrez-Larraya, F; Jabón, A | 1 |
Barchi, RL; Davison, K; Dugrenier, N; Estep, K; Ezrin, AM; Josef, K; Kallen, RG; Krafte, DS; Silver, PJ | 1 |
Higuchi, M; Itomine, T; Matsuzaki, T; Nakasone, J; Noguchi, K; Ojiri, Y; Sakanashi, M; Shiroma, N | 1 |
Hayashi, Y; Kamibayashi, T; Kawabata, K; Sumikawa, K; Takada, K; Yamatodani, A; Yoshiya, I | 1 |
Liu, JX; Ohtsuka, Y; Sakai, Y; Takeo, S; Tanonaka, K | 1 |
Asayama, J; Inoue, D; Inoue, M; Ishibashi, K; Nakagawa, M; Omori, I; Sakai, R; Yamahara, Y | 1 |
Greenberg, RM; Greenspon, AJ; Kidwell, GA; Volosin, KJ | 1 |
Akaike, N; Inomata, N; Ishihara, T; Ohno, T | 1 |
Barrett, TD; Hayes, ES; Walker, MJ | 1 |
Hatakeyama, N; Inoko, M; Kihara, Y; Momose, Y; Sasayama, S | 1 |
Catterall, WA; McPhee, JC; Ragsdale, DS; Scheuer, T | 1 |
Ito, K; Koike, H; Nagafuchi, K; Taga, A; Yorikane, R | 1 |
Adgey, AA; Allen, JD; Devine, AB; Stewart, AJ | 1 |
Aupetit, JF; Faucon, G; Loufoua-Moundanga, J; Timour, Q | 1 |
Casanova, JM; De Micheli, A; Iturralde, P; Medrano, GA | 1 |
Kondo, T; Kubota, I; Tachibana, H; Tomoike, H; Yamaki, M | 1 |
Fernández del Pozo, B; Fernández, C; Pérez-Vizcaíno, F; Tamargo, J; Zaragozá, F | 1 |
Annoura, M; Arakawa, K; Ideishi, M; Kumagai, K; Matsuo, K | 1 |
Imagawa, N; Sato, S | 1 |
Ito, H; Nakamura, W; Segawa, K; Tanaka, S; Yoshimoto, N | 1 |
Kubota, I; Tachibana, H; Tomoike, H; Watanabe, T; Yamaki, M | 2 |
Fujiki, A; Hayashi, H; Inoue, H; Mizumaki, K; Nagasawa, H; Usui, M | 1 |
Kubota, I; Tachibana, H; Tomoike, H; Watanabe, T; Yamaki, M; Yamauchi, S | 2 |
Erzouki, HK; Goldberg, SR; Schindler, CW | 1 |
Benhorin, J; Goldmit, M; Kass, RS; Kerem, B; Medina, A; Taub, R; Windman, I | 1 |
Abriel, H; Benhorin, J; Kass, RS; Kerem, B; Wehrens, XH | 1 |
Carboni, M; Chandra, R; Grant, AO; Keller, C; Starmer, CF | 1 |
Kawano, Y; Mineda, Y; Nakata, Y; Nakazato, K; Nakazato, Y; Sekita, G; Sumiyoshi, M; Tokano, T; Yamashita, H; Yasuda, M | 1 |
Azegami, K; Hiejima, K; Hirao, K; Horikawa, T; Kawabata, M; Motokawa, K; Suzuki, F; Suzuki, K | 1 |
Curtis, MJ; Farkas, A | 1 |
Hancox, JC; Paul, AA; Witchel, HJ | 1 |
Imai, H; Matoba, Y; Nakagawa, M; Shiraishi, H; Shirayama, T; Yoshida, S | 1 |
Hara, H; Ikeda-Murakami, K; Inuo, K; Izumi, T; Kojima, J; Niwano, S; Saito, J; Yoshida, T | 2 |
Blaker, PA; Davies, M; Hall, SM; Kapoor, R; Smith, KJ | 1 |
Atkins, J; Kass, RS; Liu, H | 1 |
Katoh, T; Ono, T; Sutovsky, I; Takano, T; Takayama, H | 1 |
Kubota, I; Nagai, S; Takeishi, Y | 1 |
Dohi, S; Iida, H; Oda, A; Osawa, Y; Tanahashi, S | 1 |
Esato, M; Inoue, N; Kakugawa, H; Kametani, R; Kanemoto, M; Matsuzaki, M; Sawa, A; Shimizu, A; Ueyama, T; Yamagata, T; Yoshiga, Y | 1 |
Carr, DB; Challapalli, V; Lau, J; McNicol, ED; Tremont-Lukats, IW | 1 |
Chen, YW; Cheng, KI; Chu, CC; Chu, KS; Huang, KL; Tzeng, JI; Wang, JJ | 1 |
Furukawa, T; Hachiya, H; Higuchi, K; Hirao, K; Isobe, M; Kawabata, M; Okada, H; Sasaki, T | 1 |
Aoyama, H; Enomoto, M; Hirayama, A; Imai, S; Kushiro, T; Saito, F; Takase, H; Yagi, H; Yamaji, S; Yokoyama, K | 1 |
Gallacher, DJ; Lu, HR; Rohrbacher, J; Van Ammel, K; Vlaminckx, E; Yan, GX | 1 |
Bruno, C; Conte Camerino, D; Costanza, T; Desaphy, JF; Dipalma, A; Franchini, C; George, A; Lentini, G | 1 |
Faggioni, M; Hasdemir, C; Hwang, HS; Knollmann, BC; Laver, D; Mehra, D; Turhan, K; Yin, H | 1 |
Bankston, JR; Bayer, JD; Christini, DJ; Clancy, CE; Jeng, MT; Kang, C; Kass, RS; Moreno, JD; Ripplinger, CM; Trayanova, NA; Wang, L; Yang, PC; Zhu, ZI | 1 |
Favier, JC; Landy, C; Plancade, D; Raynaud, L; Schaeffer, E | 1 |
Osadchii, OE | 1 |
Aiba, T; Ishibashi, K; Kamakura, S; Kamakura, T; Kimura, T; Kusano, K; Makiyama, T; Miyamoto, K; Nakajima, I; Noda, T; Ogawa, H; Okamura, H; Shimizu, W; Takaki, H; Wada, M; Yasuda, S | 1 |
Akin, I; Behnes, M; Borggrefe, M; Dworacek, J; El-Battrawy, I; Lang, S; Liebe, V; Meister, S; Patocskai, B; Rudic, B; Tiburcy, M; Tülümen, E; Utikal, J; Wieland, T; Yücel, G; Zhao, Z; Zhou, XB; Zimmermann, WH | 1 |
Kleinlogel, S; Streit, J | 1 |
Clancy, CE; DeMarco, KR; Nguyen, PT; Vorobyov, I; Yarov-Yarovoy, V | 1 |
Andrews, LM; Koch, BCP; van der Nagel, BCH; van Domburg, B | 1 |
Sijm, DTHM; Tukker, AM; van Kleef, RGDM; Vrolijk, MF; Westerink, RHS | 1 |
23 review(s) available for flecainide and lidocaine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
The treatment of ventricular rhythm disturbances.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Disopyramide; Electric Countershock; Electric Stimulation; Electrocardiography; Exercise Test; Flecainide; Heart Ventricles; Humans; Lidocaine; Phenytoin; Piperidines; Procainamide; Quinidine; Risk; Tachycardia; Tocainide; United States; Ventricular Fibrillation; Verapamil | 1986 |
Ventricular arrhythmias. An assessment of newer therapeutic agents.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Flecainide; Humans; Lidocaine; Mexiletine; Tocainide; United States | 1989 |
Antiarrhythmic drug therapy. Recent advances and current status.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Disopyramide; Drug Administration Schedule; Encainide; Flecainide; Heart Conduction System; Humans; Imidazoles; Lidocaine; Mexiletine; Moricizine; Myocardial Contraction; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tocainide; Verapamil | 1985 |
Clinical pharmacology of old and new antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Biological Availability; Bretylium Compounds; Disopyramide; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Tocainide | 1985 |
Antiarrhythmic drugs.
Topics: Action Potentials; Adrenergic beta-Antagonists; Amiodarone; Anilides; Anti-Arrhythmia Agents; Bretylium Compounds; Calcium Channel Blockers; Cell Membrane; Disopyramide; Electrophysiology; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1986 |
Clinical pharmacology of antiarrhythmic agents.
Topics: Adrenergic beta-Antagonists; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Calcium Channel Blockers; Electrophysiology; Encainide; Flecainide; Heart Conduction System; Humans; Lidocaine; Moricizine; Phenothiazines; Piperidines; Quaternary Ammonium Compounds; Sotalol; Tocainide | 1985 |
Effects of congestive heart failure on the pharmacokinetics and pharmacodynamics of antiarrhythmic agents.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Digitalis; Disopyramide; Drug Interactions; Encainide; Flecainide; Half-Life; Heart Failure; Hemodynamics; Humans; Kidney; Kinetics; Lidocaine; Liver; Piperidines; Plants, Medicinal; Plants, Toxic; Potassium; Procainamide; Quinidine; Regional Blood Flow; Tocainide | 1986 |
Cardiac arrhythmias in the elderly: antiarrhythmic drug treatment.
Topics: Aged; Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Compounds; Digoxin; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Propranolol; Quinidine; Tocainide; Verapamil | 1986 |
Antiarrhythmic drug therapy of ventricular arrhythmias.
Topics: Amiodarone; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bretylium Tosylate; Disopyramide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Phenytoin; Piperidines; Procainamide; Propafenone; Propiophenones; Quinidine; Sotalol; Tocainide; Verapamil | 1986 |
Antiarrhythmic agents for chronic ventricular arrhythmias.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Procainamide; Propranolol; Quinidine; Tocainide | 1987 |
New antiarrhythmic drugs: tocainide, mexiletine, flecainide, encainide, and amiodarone.
Topics: Administration, Oral; Amiodarone; Anilides; Anti-Arrhythmia Agents; Drug Interactions; Encainide; Flecainide; Heart Conduction System; Humans; Lidocaine; Mexiletine; Tachycardia; Tocainide | 1987 |
Antiarrhythmic drug therapy (Part 2). Benefits and hazards.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1985 |
Hemodynamic effects of antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Bretylium Compounds; Calcium Channel Blockers; Disopyramide; Dose-Response Relationship, Drug; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Myocardial Contraction; Phenytoin; Piperidines; Procainamide; Quinidine; Tocainide | 1983 |
Clinical profiles of newer class I antiarrhythmic agents--tocainide, mexiletine, encainide, flecainide and lorcainide.
Topics: Administration, Oral; Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Dose-Response Relationship, Drug; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Injections, Intravenous; Kinetics; Lidocaine; Mexiletine; Piperidines; Tocainide | 1983 |
Therapy with investigational antiarrhythmic drugs.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Piperidines; Tocainide | 1984 |
Haemodynamic effects of encainide, flecainide, lorcainide and tocainide.
Topics: Anilides; Anti-Arrhythmia Agents; Benzeneacetamides; Encainide; Flecainide; Hemodynamics; Humans; Lidocaine; Piperidines; Tocainide | 1984 |
Cardiac electrophysiology of four new antiarrhythmic drugs--encainide, flecainide, lorcainide and tocainide.
Topics: Action Potentials; Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Electrocardiography; Electrophysiology; Encainide; Flecainide; Heart; Heart Conduction System; Humans; Lidocaine; Piperidines; Sinoatrial Node; Tocainide | 1984 |
Comparison of the efficacy of newly developed antiarrhythmic drugs in the treatment of ventricular tachyarrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzeneacetamides; Coronary Disease; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Myocardial Infarction; Piperidines; Tachycardia; Tocainide; Ventricular Fibrillation | 1984 |
Investigational antiarrhythmic drugs for the treatment of ventricular rhythm disturbances.
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Encainide; Flecainide; Humans; Imipramine; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Tocainide | 1984 |
[New antiarrythmic drugs: mexiletine, tocainide, lorcainide, encainide, flecainide, propafenone, cipralan, sotalol].
Topics: Anilides; Animals; Anti-Arrhythmia Agents; Benzeneacetamides; Electrophysiology; Encainide; Flecainide; Hemodynamics; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone; Propiophenones; Sotalol; Tocainide | 1982 |
[Tachycardias: considerations in childhood in the 90s].
Topics: Adenosine; Adolescent; Adult; Amiodarone; Atrial Flutter; Child; Child, Preschool; Electrocardiography; Ergometry; Flecainide; Heart; Heart Ventricles; Humans; Infant; Infant, Newborn; Lidocaine; Middle Aged; Propafenone; Sotalol; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Paroxysmal; Tachycardia, Supraventricular; Tachycardia, Ventricular | 1993 |
Systemic administration of local anesthetic agents to relieve neuropathic pain.
Topics: Administration, Oral; Anesthetics, Intravenous; Anesthetics, Local; Flecainide; Humans; Lidocaine; Mexiletine; Nervous System Diseases; Pain; Randomized Controlled Trials as Topic; Tocainide | 2005 |
8 trial(s) available for flecainide and lidocaine
Article | Year |
---|---|
Relative efficacy and safety of intravenous drugs for termination of sustained ventricular tachycardia.
Topics: Adenosine; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Clinical Trials as Topic; Disopyramide; Drug Administration Schedule; Drug Evaluation; Drug Therapy, Combination; Electric Countershock; Electrocardiography; Flecainide; Humans; Hypotension; Injections, Intravenous; Lidocaine; Middle Aged; Recurrence; Sotalol; Tachycardia | 1990 |
Comparative haemodynamic effects of intravenous lignocaine, disopyramide and flecainide in uncomplicated acute myocardial infarction.
Topics: Adult; Aged; Disopyramide; Flecainide; Hemodynamics; Humans; Infusions, Intravenous; Lidocaine; Male; Middle Aged; Myocardial Infarction; Prospective Studies | 1986 |
[Effect of class I anti-arrhythmia agents on the signal-averaged ECG].
Topics: Anti-Arrhythmia Agents; Cardiomyopathy, Dilated; Clinical Trials as Topic; Coronary Disease; Disopyramide; Electrocardiography; Female; Flecainide; Heart Ventricles; Humans; Lidocaine; Male; Middle Aged; Myocardial Infarction; Random Allocation; Signal Processing, Computer-Assisted; Tachycardia; Tocainide | 1988 |
Selection of an antiarrhythmic drug for a sudden-death-prevention trial.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Clinical Trials as Topic; Death, Sudden; Encainide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Moricizine; Morpholines; Phenothiazines; Piperidines; Tocainide; Verapamil | 1982 |
Mechanism of antiarrhythmic effects of class Ic drugs in paroxysmal atrial fibrillation in man.
Topics: Administration, Oral; Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Cardiac Pacing, Artificial; Electrocardiography; Electrophysiology; Female; Flecainide; Humans; Lidocaine; Male; Middle Aged | 1998 |
Bepridil prevents paroxysmal atrial fibrillation by a class III antiarrhythmic drug effect.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Electrocardiography; Female; Flecainide; Humans; Lidocaine; Male; Middle Aged | 2003 |
Low-dose flecainide infusion followed by oral pilsicainide is highly effective and safe for paroxysmal atrial fibrillation.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Drug Therapy, Combination; Female; Flecainide; Humans; Infusions, Intravenous; Lidocaine; Male; Middle Aged | 2003 |
Use of bepridil in combination with Ic antiarrhythmic agent in converting persistent atrial fibrillation to sinus rhythm.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Natriuretic Factor; Bepridil; Drug Therapy, Combination; Electrocardiography; Female; Flecainide; Follow-Up Studies; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Natriuretic Peptide, Brain; Sinoatrial Node; Treatment Outcome | 2008 |
103 other study(ies) available for flecainide and lidocaine
Article | Year |
---|---|
Synthesis and cardiac electrophysiological activity of aryl-substituted derivatives of the class III antiarrhythmic agent sematilide. Potential class I/III agents.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Chemical Phenomena; Chemistry; Dogs; Drug Design; Electrophysiology; Guinea Pigs; In Vitro Techniques; Ouabain; Procainamide; Purkinje Fibers; Structure-Activity Relationship | 1990 |
Ester derivatives of 2,6-bis(1-pyrrolidinylmethyl)-4-benzamidophenol as short-acting antiarrhythmic agents. 1.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Esters; Guinea Pigs; Humans; Male; Pyrrolidines | 1989 |
4,5-Dihydro-1-phenyl-1H-2,4-benzodiazepines: novel antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Benzodiazepines; Cats; Disease Models, Animal; Dogs; Guinea Pigs; Heart Ventricles; Male; Myocardial Contraction; Myocardial Infarction; Potassium Channels; Rats; Rats, Sprague-Dawley; Refractory Period, Electrophysiological; Sodium Channels; Structure-Activity Relationship | 1993 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Synthesis and biological studies of novel 2-aminoalkylethers as potential antiarrhythmic agents for the conversion of atrial fibrillation.
Topics: Administration, Oral; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Biological Availability; Cell Line; Crystallography, X-Ray; Cyclohexanes; Dogs; Electric Stimulation; Ethers; Female; Humans; Male; Mice; Molecular Structure; Myocardial Ischemia; Patch-Clamp Techniques; Potassium Channels, Voltage-Gated; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Rats, Wistar; Sodium Channels; Stereoisomerism; Structure-Activity Relationship | 2007 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Predicting phospholipidosis using machine learning.
Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine | 2010 |
Predicting hERG activities of compounds from their 3D structures: development and evaluation of a global descriptors based QSAR model.
Topics: Computer Simulation; Ether-A-Go-Go Potassium Channels; Humans; Molecular Structure; Organic Chemicals; Quantitative Structure-Activity Relationship | 2011 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
Topics: 2,4-Dinitrophenol; Action Potentials; Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Dinitrophenols; Disopyramide; Flecainide; Glyburide; Guinea Pigs; Heart Ventricles; Imidazoles; Lidocaine; Mexiletine; Myocardium; Piperidines; Potassium; Procainamide; Pyridines | 1992 |
[Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration].
Topics: Administration, Oral; Anti-Arrhythmia Agents; Aprindine; Flecainide; Humans; Imidazoles; Lidocaine; Mexiletine; Piperidines; Propafenone | 1992 |
A new ECG measure (RSh) for detecting possible sodium channel blockade in vivo in rats.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Electrocardiography; Flecainide; Heart Rate; Lidocaine; Male; Quinidine; Rats; Rats, Inbred Strains; Sodium; Sodium Channels | 1992 |
[Estimation of depressant effects of class I antiarrhythmic drugs on intraventricular conduction--rate-dependent effects on QRS duration].
Topics: Anti-Arrhythmia Agents; Aprindine; Depression, Chemical; Disopyramide; Electrocardiography; Flecainide; Heart Conduction System; Heart Rate; Humans; Lidocaine; Mexiletine; Sodium Channels; Ventricular Function | 1992 |
Effect of antiarrhythmic drugs on choline uptake in cardiac cells in culture.
Topics: Amiodarone; Animals; Anti-Arrhythmia Agents; Cells, Cultured; Chick Embryo; Choline; Dose-Response Relationship, Drug; Encainide; Flecainide; Heart; Lidocaine; Myocardium; Propafenone; Tocainide | 1992 |
Effects of flecainide on ventricular arrhythmias, abnormal automaticity and activation in a canine model of myocardial infarction.
Topics: Animals; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Electrocardiography; Flecainide; Heart Rate; Heart Ventricles; Injections, Intravenous; Lidocaine; Myocardial Infarction | 1992 |
Differential effects on action potential duration of class IA, B and C antiarrhythmic drugs: modulation by stimulation rate and extracellular K+ concentration.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Disopyramide; Dogs; Flecainide; Heart Rate; In Vitro Techniques; Lidocaine; Potassium Channels; Purkinje Fibers; Sodium Channels | 1991 |
Electrophysiological effects of sodium channel blockers on guinea pig left atrium.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Aprindine; Atrial Function; Atrial Function, Left; Diastole; Disopyramide; Electrophysiology; Female; Flecainide; Guinea Pigs; Heart; Heart Atria; Kinetics; Lidocaine; Male; Sodium Channels | 1991 |
Antiarrhythmic and cardiovascular profiles of the fused indole compound (3aR,12R,12aR,12bS)-12-amino-2,3,3a,4,11,12,12a,12b-octahydro-10-hydrox yisoquino [2,1,8-lma]carbazol-5(1H)-one hydrochloride 1.5 hydrate.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Carbazoles; Chloroform; Disopyramide; Dogs; Female; Flecainide; Heart; Heart Conduction System; Hemodynamics; Isoquinolines; Lidocaine; Male; Mexiletine; Mice; Mice, Inbred ICR; Myocardial Contraction; Ouabain | 1991 |
Mechanisms of the anticholinergic effect of SUN 1165 in comparison with flecainide, disopyramide and quinidine in single atrial myocytes isolated from guinea-pig.
Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Disopyramide; Flecainide; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Guinea Pigs; Heart; In Vitro Techniques; Lidocaine; Male; Myocardium; Parasympatholytics; Potassium Channels; Quinidine; Receptors, Cholinergic | 1991 |
Frequency dependent effects of tocainide, quinidine, and flecainide on conduction as reflected in the rise time of the monophasic action potential in the isolated guinea pig heart.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Flecainide; Guinea Pigs; Heart Conduction System; Heart Ventricles; In Vitro Techniques; Kinetics; Lidocaine; Quinidine; Tocainide | 1991 |
Arrhythmogenic activities of antiarrhythmic drugs in conscious hypokalemic dogs with atrioventricular block: comparison between quinidine, lidocaine, flecainide, propranolol and sotalol.
Topics: Animals; Anti-Arrhythmia Agents; Bradycardia; Consciousness; Diuretics; Dogs; Electrocardiography, Ambulatory; Electrolytes; Electrophysiology; Female; Flecainide; Heart Block; Hypocalcemia; Lidocaine; Male; Propranolol; Quinidine; Sotalol | 1991 |
Reversed-phase LC resolutions of chiral antiarrhythmic agents via derivatization with homochiral isothiocyanates.
Topics: Anti-Arrhythmia Agents; Chromatography, Liquid; Flecainide; Humans; Indicators and Reagents; Lidocaine; Male; Mexiletine; Propafenone; Thiocyanates; Tocainide | 1990 |
Mechanisms of termination of reentrant atrial arrhythmias by class I and class III antiarrhythmic agents.
Topics: Animals; Anti-Arrhythmia Agents; Disopyramide; Dogs; Electrocardiography; Flecainide; Heart Conduction System; Heart Rate; Lidocaine; Piperidines; Propafenone; Sotalol | 1989 |
Acute effects of combination of IB and IC antiarrhythmics for the treatment of ventricular tachycardia.
Topics: Anilides; Anti-Arrhythmia Agents; Blood Pressure; Drug Therapy, Combination; Electric Stimulation; Electrocardiography; Encainide; Flecainide; Heart Rate; Hemodynamics; Humans; Lidocaine; Male; Middle Aged; Refractory Period, Electrophysiological; Tachycardia | 1989 |
Orthostatic hypotension: clinical spectrum and approach to treatment.
Topics: Adult; Aged; Amiodarone; Disopyramide; Female; Flecainide; Humans; Hypotension, Orthostatic; Lidocaine; Male; Middle Aged; Piperidines; Procainamide; Quinidine; Sympathomimetics; Tocainide | 1986 |
Metabolites of antiarrhythmic drugs: are they clinically important?
Topics: Anilides; Anti-Arrhythmia Agents; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Procainamide; Quinidine | 1986 |
Second generation antiarrhythmic agents: have we reached antiarrhythmic Nirvana?
Topics: Amiodarone; Anilides; Anti-Arrhythmia Agents; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Tocainide | 1987 |
Drug therapy: flecainide and tocainide.
Topics: Aged; Anti-Arrhythmia Agents; Flecainide; Humans; Lidocaine; Tocainide | 1987 |
Flecainide-induced sustained ventricular tachycardia successfully treated with lidocaine.
Topics: Aged; Electrocardiography; Flecainide; Humans; Lidocaine; Male; Tachycardia | 1987 |
Refractory ventricular tachycardia with flecainide.
Topics: Aged; Anti-Arrhythmia Agents; Flecainide; Heart Ventricles; Humans; Lidocaine; Male; Middle Aged; Piperidines; Tachycardia | 1986 |
Haemodynamic effects of class I antiarrhythmic agents.
Topics: Anti-Arrhythmia Agents; Disopyramide; Flecainide; Hemodynamics; Humans; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide | 1985 |
New drugs in the management of ventricular arrhythmias.
Topics: Acecainide; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Benzeneacetamides; Bretylium Compounds; Drug Interactions; Encainide; Flecainide; Heart Ventricles; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Propafenone; Propiophenones; Tocainide | 1984 |
Antiarrhythmic drugs.
Topics: Adrenergic beta-Antagonists; Amiodarone; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Disopyramide; Flecainide; Humans; Kinetics; Lidocaine; Mexiletine; Piperidines; Procainamide; Quinidine; Tocainide; Verapamil | 1983 |
New directions in antiarrhythmic drug therapy.
Topics: Adrenergic beta-Antagonists; Ajmaline; Amiodarone; Anilides; Anti-Arrhythmia Agents; Aprindine; Benzeneacetamides; Bepridil; Bethanidine; Bretylium Tosylate; Death, Sudden; Disopyramide; Encainide; Flecainide; Humans; Lidocaine; Mexiletine; Moricizine; Phenothiazines; Piperidines; Procainamide; Propafenone; Propiophenones; Pyrrolidines; Quinidine; Tachycardia; Tocainide; Verapamil | 1984 |
The clinical pharmacology of lidocaine congeners--review of encainide, flecainide, lorcainide and tocainide.
Topics: Anilides; Benzeneacetamides; Encainide; Flecainide; Humans; Kinetics; Lidocaine; Piperidines; Tocainide | 1984 |
The use of tocainide, encainide, lorcainide and flecainide for supraventricular arrhythmias.
Topics: Anilides; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Atrioventricular Node; Benzeneacetamides; Encainide; Flecainide; Heart Atria; Humans; Lidocaine; Piperidines; Tachycardia; Tocainide; Wolff-Parkinson-White Syndrome | 1984 |
Antiarrhythmic and electrophysiologic actions of flecainide in animal models.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disease Models, Animal; Dogs; Electrophysiology; Flecainide; Heart Conduction System; In Vitro Techniques; Lidocaine; Piperidines; Procainamide; Quinidine; Rabbits | 1984 |
Class 1 antiarrhythmic drugs--characteristic electrocardiographic differences when assessed by atrial and ventricular pacing.
Topics: Action Potentials; Aged; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Coronary Disease; Disopyramide; Electrocardiography; Female; Flecainide; Humans; Lidocaine; Male; Middle Aged; Piperidines | 1984 |
[Anti-arrhythmia effect of flecainide in acute myocardial infarct in comparison with lidocaine].
Topics: Acute Disease; Animals; Arrhythmias, Cardiac; Dogs; Flecainide; Lidocaine; Myocardial Infarction; Piperidines | 1981 |
Antiarrhythmic effects of bisaramil on triggered arrhythmias produced by intracoronary injection of digitalis and adrenaline in the dog.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bridged Bicyclo Compounds, Heterocyclic; Chlorobenzenes; Digitalis Glycosides; Disease Models, Animal; Disopyramide; Dogs; Epinephrine; Female; Flecainide; Injections, Intra-Arterial; Lidocaine; Male; Ouabain; Verapamil | 1995 |
Effects of E-4031 on atrial fibrillation threshold in guinea pig atria: comparative study with class I antiarrhythmic drugs.
Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Atrial Function; Disopyramide; Electric Stimulation; Female; Flecainide; Guinea Pigs; Heart Atria; Heart Conduction System; In Vitro Techniques; Lidocaine; Male; Piperidines; Procainamide; Pyridines; Refractory Period, Electrophysiological | 1994 |
Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Blood Gas Analysis; Electrophysiology; Flecainide; Glyburide; Guanidines; In Vitro Techniques; Lidocaine; Male; Myocardial Contraction; Pinacidil; Potassium Channels; Quinidine; Rabbits; Refractory Period, Electrophysiological; Vasodilator Agents | 1993 |
Frequency dependent effects of class I antiarrhythmic agents studied in patients with implanted pacemakers.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Arrhythmias, Cardiac; Cardiac Pacing, Artificial; Cross-Over Studies; Disopyramide; Electrocardiography; Flecainide; Humans; Lidocaine; Pacemaker, Artificial | 1994 |
Pharmacological modulation of human cardiac Na+ channels.
Topics: Animals; Azetidines; Cardiotonic Agents; Electrophysiology; Female; Flecainide; Humans; Lidocaine; Mercaptopurine; Myocardium; Oocytes; Piperazines; Quinidine; RNA, Complementary; Sodium Channels; Tetrodotoxin; Transcription, Genetic; Xenopus laevis | 1994 |
Effects of pilsicainide on systemic hemodynamics and cardiac function of anesthetized dogs.
Topics: Anesthesia, Intravenous; Animals; Anti-Arrhythmia Agents; Depression, Chemical; Dogs; Female; Flecainide; Heart; Hemodynamics; Lidocaine; Male; Myocardial Contraction; Propafenone | 1993 |
Comparative efficacy of antiarrhythmic agents in preventing halothane-epinephrine arrhythmias in rats.
Topics: Amiodarone; Anesthesia, Inhalation; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epinephrine; Flecainide; Halothane; Isoflurane; Lidocaine; Male; Piperidines; Pyridines; Rats; Rats, Sprague-Dawley; Verapamil | 1993 |
Improvement of ischemia/reperfusion-induced contractile dysfunction of perfused hearts by class Ic antiarrhythmic agents.
Topics: Adenosine Triphosphate; Animals; Anti-Arrhythmia Agents; Creatine Kinase; Flecainide; Heart; Lidocaine; Male; Metals; Myocardial Contraction; Myocardial Ischemia; Myocardial Reperfusion Injury; Myocardium; Perfusion; Rats; Rats, Wistar; Ventricular Function, Left | 1993 |
Effects of pilsicainide on the atrial fibrillation threshold in guinea pig atria. A comparative study with disopyramide, lidocaine and flecainide.
Topics: Animals; Anti-Arrhythmia Agents; Atrial Fibrillation; Disopyramide; Electrophysiology; Female; Flecainide; Guinea Pigs; Heart; Heart Atria; In Vitro Techniques; Lidocaine; Male | 1993 |
Use-dependent prolongation of ventricular tachycardia cycle length by type I antiarrhythmic drugs in humans.
Topics: Adult; Aged; Anti-Arrhythmia Agents; Electrocardiography; Female; Flecainide; Humans; Lidocaine; Male; Middle Aged; Procainamide; Tachycardia, Ventricular; Time Factors | 1993 |
Antiarrhythmic agents act differently on the activation phase of the ACh-response in guinea-pig atrial myocytes.
Topics: Acetylcholine; Animals; Anti-Arrhythmia Agents; Disopyramide; Electric Conductivity; Flecainide; Guinea Pigs; Lidocaine; Male; Myocardium; Potassium; Potassium Channels; Propafenone | 1993 |
Lack of selectivity for ventricular and ischaemic tissue limits the antiarrhythmic actions of lidocaine, quinidine and flecainide against ischaemia-induced arrhythmias.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Dose-Response Relationship, Drug; Electrocardiography; Electrophysiology; Flecainide; Heart; Heart Rate; Heart Ventricles; In Vitro Techniques; Lidocaine; Male; Myocardial Ischemia; Quinidine; Rats; Rats, Sprague-Dawley | 1995 |
Mechanisms of negative inotropic effects of class Ic antiarrhythmic agents: comparative study of the effects of flecainide and pilsicainide on intracellular calcium handling in dog ventricular myocardium.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Calcium Channels; Depression, Chemical; Dogs; Dose-Response Relationship, Drug; Flecainide; Heart Ventricles; Lidocaine; Myocardial Contraction; Myocardium; Sarcolemma | 1996 |
Common molecular determinants of local anesthetic, antiarrhythmic, and anticonvulsant block of voltage-gated Na+ channels.
Topics: Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Anticonvulsants; Binding Sites; Dose-Response Relationship, Drug; Flecainide; Ion Channel Gating; Lidocaine; Mutagenesis, Site-Directed; Mutation; Phenytoin; Quinidine; Rats; Recombinant Proteins; Sodium Channels; Structure-Activity Relationship | 1996 |
Possible involvement of altered Na+ -Ca2+ exchange in negative inotropic effects of class I antiarrhythmic drugs on rabbit and rat ventricles.
Topics: Animals; Anti-Arrhythmia Agents; Calcium; Calcium Channels; Carbazoles; Depression, Chemical; Dose-Response Relationship, Drug; Flecainide; In Vitro Techniques; Isoquinolines; Lidocaine; Male; Myocardial Contraction; Rabbits; Rats; Rats, Wistar; Ryanodine; Sodium; Sodium Channels | 1996 |
Effects of blockade of fast and slow inward current channels on ventricular fibrillation in the pig heart.
Topics: Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Disopyramide; Electrocardiography; Flecainide; Lidocaine; Mexiletine; Models, Biological; Sodium-Potassium-Exchanging ATPase; Swine; Ventricular Fibrillation; Verapamil | 1996 |
Ischaemia-induced loss or reversal of the effects of the class I antiarrhythmic drugs on vulnerability to fibrillation.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Coronary Vessels; Disopyramide; Electric Stimulation; Electrophysiology; Female; Flecainide; Heart Conduction System; In Vitro Techniques; Injections, Intravenous; Lidocaine; Male; Myocardial Ischemia; Swine; Ventricular Fibrillation | 1997 |
Effects of verapamil in ventricular tachycardias. An experimental and clinical study.
Topics: Aconitine; Adult; Animals; Anti-Arrhythmia Agents; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Flecainide; Humans; Lidocaine; Tachycardia, Ventricular; Verapamil | 1997 |
Electrophysiologic effects of sodium channel blockade on anisotropic conduction and conduction block in canine myocardium: preferential slowing of longitudinal conduction by flecainide versus disopyramide or lidocaine.
Topics: Animals; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Disopyramide; Dogs; Electric Conductivity; Electrophysiology; Flecainide; Heart Conduction System; Heart Ventricles; Lidocaine; Sodium Channels; Ventricular Fibrillation | 1997 |
Effects of several class I antiarrhythmic drugs on isolated rat aortic vascular smooth muscle.
Topics: Animals; Anti-Arrhythmia Agents; Aorta; Desipramine; Disopyramide; Flecainide; Imipramine; In Vitro Techniques; Lidocaine; Male; Mexiletine; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; Quinidine; Rats; Rats, Sprague-Dawley | 1997 |
Effects of lidocaine and mexiletine on defibrillation energy requirements in animals treated with flecainide.
Topics: Animals; Anti-Arrhythmia Agents; Dogs; Electric Countershock; Flecainide; Lidocaine; Mexiletine; Ventricular Fibrillation | 1998 |
Class IC antiarrhythmic drugs, flecainide and pilsicainide, produce ST segment elevation simulating inferior myocardial ischemia.
Topics: Anti-Arrhythmia Agents; Diagnosis, Differential; Drug Therapy, Combination; Electrocardiography; Flecainide; Heart; Humans; Lidocaine; Male; Middle Aged; Myocardial Ischemia; Tachycardia, Ventricular | 1998 |
Decrease in the high frequency QRS components depending on the local conduction delay.
Topics: Animals; Disopyramide; Dogs; Electrocardiography; Flecainide; Fourier Analysis; Heart Conduction System; Lidocaine; Sodium Channel Blockers; Time | 1998 |
ST segment elevation in the right precordial leads induced with class IC antiarrhythmic drugs: insight into the mechanism of Brugada syndrome.
Topics: Anti-Arrhythmia Agents; Atrial Fibrillation; Electrocardiography; Flecainide; Follow-Up Studies; Heart Rate; Humans; Lidocaine; Male; Middle Aged; Procainamide; Recurrence; Tachycardia, Paroxysmal; Tachycardia, Ventricular; Wolff-Parkinson-White Syndrome | 1999 |
Intracoronary flecainide induces ST alternans and reentrant arrhythmia on intact canine heart: A role of 4-aminopyridine-sensitive current.
Topics: 4-Aminopyridine; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Vessels; Disopyramide; Dogs; Electrocardiography; Flecainide; Injections; Lidocaine; Piperidines; Pyridines; Sodium Channels; Ventricular Fibrillation; Verapamil | 1999 |
Comparison of cocaine and Na+ channel blockers on cardio-respiratory function in the rabbit.
Topics: Animals; Anti-Arrhythmia Agents; Blood Pressure; Cocaine; Dopamine Uptake Inhibitors; Electrocardiography; Female; Flecainide; Heart; Heart Rate; Lidocaine; Male; Procainamide; Quinidine; Rabbits; Respiration; Sodium Channel Blockers | 1999 |
Effects of flecainide in patients with new SCN5A mutation: mutation-specific therapy for long-QT syndrome?
Topics: Anti-Arrhythmia Agents; Case-Control Studies; Electrocardiography; Female; Flecainide; Heart; Heterozygote; Humans; Injections, Intravenous; Lidocaine; Long QT Syndrome; Male; Mutation; NAV1.5 Voltage-Gated Sodium Channel; Pedigree; Sodium Channels | 2000 |
Direct effects of class I antiarrhythmic drugs on epicardial electrograms in dogs.
Topics: Animals; Anti-Arrhythmia Agents; Disopyramide; Dogs; Electrocardiography; Flecainide; Lidocaine; Pericardium | 1999 |
Molecular pharmacology of the sodium channel mutation D1790G linked to the long-QT syndrome.
Topics: Anti-Arrhythmia Agents; Cell Line; Dose-Response Relationship, Drug; Flecainide; Genetic Linkage; Humans; Kinetics; Lidocaine; Long QT Syndrome; Membrane Potentials; NAV1.5 Voltage-Gated Sodium Channel; Point Mutation; Sodium Channel Blockers; Sodium Channels; Substrate Specificity | 2000 |
Anisotropic effects of sodium channel blockers on the wavelength for ventricular excitation in dogs.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Disopyramide; Dogs; Electrocardiography; Electrophysiology; Flecainide; Heart Conduction System; Heart Ventricles; Lidocaine; Sodium Channel Blockers; Sodium Channels; Tachycardia, Ventricular; Ventricular Fibrillation; Ventricular Function | 2000 |
Block of wild-type and inactivation-deficient cardiac sodium channels IFM/QQQ stably expressed in mammalian cells.
Topics: Amino Acid Substitution; Anti-Arrhythmia Agents; Cell Line; Cloning, Molecular; Disopyramide; Flecainide; Heart; Humans; Lidocaine; Membrane Potentials; Models, Biological; Myocardium; Recombinant Proteins; Sodium Channel Blockers; Sodium Channels; Transfection | 2000 |
ST segment elevation in the right precordial leads following administration of class Ic antiarrhythmic drugs.
Topics: Aged; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Atrial Fibrillation; Electrocardiography; Female; Flecainide; Humans; Lidocaine; Male; Middle Aged; Retrospective Studies | 2001 |
Syncope in patients with atrial flutter during treatment with class Ic antiarrhythmic drugs.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Flutter; Catheter Ablation; Electrocardiography; Electrophysiologic Techniques, Cardiac; Exercise; Flecainide; Humans; Lidocaine; Male; Middle Aged; Syncope; Tachycardia | 2001 |
Limited antifibrillatory effectiveness of clinically relevant concentrations of class I antiarrhythmics in isolated perfused rat hearts.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Coronary Circulation; Electrocardiography; Flecainide; Heart; Heart Rate; In Vitro Techniques; Lidocaine; Male; Myocardial Ischemia; Myocardial Reperfusion Injury; Potassium Chloride; Quinidine; Rats; Rats, Wistar; Ventricular Fibrillation | 2002 |
Inhibition of the current of heterologously expressed HERG potassium channels by flecainide and comparison with quinidine, propafenone and lignocaine.
Topics: Cation Transport Proteins; DNA-Binding Proteins; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Ether-A-Go-Go Potassium Channels; Flecainide; Humans; Lidocaine; Neural Inhibition; Potassium Channels; Potassium Channels, Voltage-Gated; Propafenone; Quinidine; Trans-Activators; Transcriptional Regulator ERG | 2002 |
Atrial fibrillation threshold predicted long-term efficacy of pharmacological treatment of patients without structural heart disease.
Topics: Aged; Anti-Arrhythmia Agents; Aprindine; Atrial Fibrillation; Disopyramide; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Treatment Outcome | 2002 |
Evaluation of the effect of bepridil on paroxysmal atrial fibrillation: relationship between efficacy and the f-f interval in surface ECG recordings.
Topics: Aged; Anti-Arrhythmia Agents; Atrial Fibrillation; Bepridil; Calcium Channel Blockers; Electrocardiography; Female; Flecainide; Humans; Lidocaine; Male; Middle Aged; Sodium Channel Blockers; Treatment Outcome | 2003 |
Blockers of sodium and calcium entry protect axons from nitric oxide-mediated degeneration.
Topics: Anesthetics, Local; Animals; Axons; Bepridil; Calcium; Calcium Channel Blockers; Electrophysiology; Flecainide; Lidocaine; Male; Nerve Degeneration; Nitric Oxide; Nitric Oxide Donors; Nitroso Compounds; Rats; Rats, Sprague-Dawley; Sodium; Sodium Channel Blockers; Sodium-Calcium Exchanger; Spinal Nerve Roots | 2003 |
Common molecular determinants of flecainide and lidocaine block of heart Na+ channels: evidence from experiments with neutral and quaternary flecainide analogues.
Topics: Anti-Arrhythmia Agents; Binding, Competitive; Cell Line; Flecainide; Humans; Intracellular Membranes; Lidocaine; Myocardium; Patch-Clamp Techniques; Sodium Channel Blockers; Sodium Channels | 2003 |
Therapeutic monitoring of class I antiarrhythmic agents using high-resolution electrocardiography instead of blood samples.
Topics: Aged; Anti-Arrhythmia Agents; Drug Monitoring; Electrocardiography; Female; Flecainide; Humans; Lidocaine; Male; Middle Aged; Piperidines | 2003 |
The effects of class Ic antiarrhythmics on tetrodotoxin-resistant Na+ currents in rat sensory neurons.
Topics: Algorithms; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Drug Interactions; Drug Resistance; Flecainide; Ganglia, Spinal; Lidocaine; Male; Neurons, Afferent; Rats; Rats, Sprague-Dawley; Sodium Channel Blockers; Sodium Channels; Tetrodotoxin | 2004 |
Differentiation of the electrophysiological effects on the atrial myocardium between the pure Na channel blocker, pilsicainide, and flecainide.
Topics: Adult; Anti-Arrhythmia Agents; Atrial Flutter; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Heart Atria; Heart Conduction System; Heart Ventricles; Humans; Lidocaine; Male; Middle Aged; Myocardium; Prospective Studies; Refractory Period, Electrophysiological; Research Design; Sodium Channel Blockers; Tachycardia, Atrioventricular Nodal Reentry; Tachycardia, Ventricular; Treatment Outcome; Wolff-Parkinson-White Syndrome | 2004 |
The cutaneous analgesic effect of class I antiarrhythmic drugs.
Topics: Analgesics; Anesthetics, Local; Animals; Anti-Arrhythmia Agents; Bupivacaine; Dose-Response Relationship, Drug; Flecainide; Injections, Subcutaneous; Lidocaine; Male; Mexiletine; Pain Measurement; Pain Threshold; Quinidine; Rats; Rats, Sprague-Dawley; Reflex; Skin; Sodium Channel Blockers; Time Factors | 2007 |
Clinical and electrophysiological characteristics of patients having atrial flutter with 1:1 atrioventricular conduction.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amiodarone; Anti-Arrhythmia Agents; Atrial Flutter; Case-Control Studies; Catheter Ablation; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Heart Atria; Heart Conduction System; Heart Ventricles; Humans; Imidazoles; Lidocaine; Male; Middle Aged; Retrospective Studies; Risk Factors | 2008 |
Predicting drug-induced slowing of conduction and pro-arrhythmia: identifying the 'bad' sodium current blockers.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; CHO Cells; Cricetinae; Cricetulus; Drug Evaluation, Preclinical; Electric Conductivity; Ether-A-Go-Go Potassium Channels; Flecainide; Heart Conduction System; In Vitro Techniques; Lidocaine; Myocardial Reperfusion Injury; Patch-Clamp Techniques; Purkinje Fibers; Rabbits; Sodium Channel Blockers; Sodium Channels; Tachycardia, Ventricular; Ventricular Fibrillation | 2010 |
Molecular determinants of state-dependent block of voltage-gated sodium channels by pilsicainide.
Topics: Brain; Cell Line; Flecainide; Heart; Humans; Lidocaine; Mexiletine; Muscle Proteins; Muscle, Skeletal; NAV1.1 Voltage-Gated Sodium Channel; NAV1.4 Voltage-Gated Sodium Channel; NAV1.5 Voltage-Gated Sodium Channel; Nerve Tissue Proteins; Patch-Clamp Techniques; Sodium Channel Blockers; Sodium Channels | 2010 |
Inhibition of cardiac Ca2+ release channels (RyR2) determines efficacy of class I antiarrhythmic drugs in catecholaminergic polymorphic ventricular tachycardia.
Topics: Analysis of Variance; Animals; Anti-Arrhythmia Agents; Calcium Channel Blockers; Calsequestrin; Defibrillators, Implantable; Disease Models, Animal; Dose-Response Relationship, Drug; Electric Countershock; Electrocardiography; Flecainide; Humans; Ion Channel Gating; Lidocaine; Male; Mice; Mice, Knockout; Mutation, Missense; Myocytes, Cardiac; Procainamide; Propafenone; Ryanodine Receptor Calcium Release Channel; Sodium Channel Blockers; Tachycardia, Ventricular; Time Factors; Young Adult | 2011 |
A computational model to predict the effects of class I anti-arrhythmic drugs on ventricular rhythms.
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Computer Simulation; Flecainide; Heart Conduction System; Heart Failure; Heart Ventricles; Humans; Kinetics; Lidocaine; Models, Cardiovascular; Rabbits; Reproducibility of Results; Sodium Channels | 2011 |
Convulsions after normal dose of lidocaine: a probable drug interaction.
Topics: Adrenergic alpha-Agonists; Aged; Anesthetics, Local; Anti-Arrhythmia Agents; Atrial Fibrillation; Brachial Plexus; Drug Interactions; Epinephrine; Female; Flecainide; Fractures, Bone; Humans; Lidocaine; Radial Nerve; Radius; Seizures | 2012 |
Effects of Na+ channel blockers on extrasystolic stimulation-evoked changes in ventricular conduction and repolarization.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Electrophysiological Phenomena; Female; Flecainide; Guinea Pigs; Heart Ventricles; Lidocaine; Mexiletine; Quinidine; Sodium Channel Blockers; Tachycardia, Ventricular | 2014 |
Significance of electrocardiogram recording in high intercostal spaces in patients with early repolarization syndrome.
Topics: Adult; Anti-Arrhythmia Agents; Brugada Syndrome; Electrocardiography; Electrophysiologic Techniques, Cardiac; Female; Flecainide; Humans; Lidocaine; Male; Prognosis; Recurrence; Risk Assessment; Ventricular Fibrillation | 2016 |
Hyperthermia Influences the Effects of Sodium Channel Blocking Drugs in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
Topics: Ajmaline; Flecainide; Hot Temperature; Humans; Lidocaine; Myocytes, Cardiac; Patch-Clamp Techniques; Pluripotent Stem Cells; Polymerase Chain Reaction; Ranolazine; Sodium Channel Blockers; Sodium Channels | 2016 |
Dynamic all-optical drug screening on cardiac voltage-gated ion channels.
Topics: Astemizole; Dose-Response Relationship, Drug; ERG1 Potassium Channel; Flecainide; Gene Expression; HEK293 Cells; High-Throughput Screening Assays; Humans; Lidocaine; Membrane Potentials; NAV1.5 Voltage-Gated Sodium Channel; Optogenetics; Patch-Clamp Techniques; Phosphines; Plasmids; Potassium Channel Blockers; Quinidine; Voltage-Gated Sodium Channel Blockers | 2018 |
Structural basis for antiarrhythmic drug interactions with the human cardiac sodium channel.
Topics: Amino Acid Sequence; Anti-Arrhythmia Agents; Binding Sites; Drug Interactions; Flecainide; Humans; Lidocaine; Models, Molecular; Molecular Docking Simulation; Molecular Dynamics Simulation; NAV1.5 Voltage-Gated Sodium Channel; Protein Binding; Protein Conformation; Sodium; Sodium Channels | 2019 |
High-throughput quantification of ten antiarrhythmic drugs in human plasma using UPLC-MS/MS.
Topics: Anti-Arrhythmia Agents; Atenolol; Bisoprolol; Carvedilol; Chromatography, High Pressure Liquid; Diltiazem; Flecainide; High-Throughput Screening Assays; Humans; Lidocaine; Metoprolol; Propranolol; Reproducibility of Results; Sotalol; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Verapamil | 2019 |
Mixture effects of tetrodotoxin (TTX) and drugs targeting voltage-gated sodium channels on spontaneous neuronal activity in vitro.
Topics: Animals; Carbamazepine; Flecainide; Humans; Lidocaine; Rats; Riluzole; Tetrodotoxin; Voltage-Gated Sodium Channels | 2023 |